Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2021-04-15 09:02 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Secora Michael Chief Financial Officer |
0 | $0 | 2,849,075 (Direct) |
View |
Ownership |
2021-04-15 09:01 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Li Dean Y Director |
0 | $0 | 3,804,549 (Direct) |
View |
Ownership |
2021-04-15 08:59 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Larson Tina Marriott President and COO |
0 | $0 | 915,000 (Direct) |
View |
Ownership |
2021-04-15 08:58 am |
N/A 2030-03-19 |
RECURSION PHARMACEUTICALS INC. | RXRX | HERSHBERG ROBERT Director |
0 | $0 | 525,000 (Direct) |
View |
Ownership |
2021-04-15 08:57 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Gibson Christopher Chief Executive Officer 10% Owner |
0 | $0 | 10,967,883 (Direct) |
View |
Ownership |
2021-04-15 08:56 am |
N/A 2030-12-30 |
RECURSION PHARMACEUTICALS INC. | RXRX | Doyle Ramona Chief Medical Officer |
0 | $0 | 750,000 (Direct) |
View |
Ownership |
2021-04-15 08:55 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Dar Zavain Director |
0 | $0 | 0 (Direct) |
View |
Ownership |
2021-04-15 08:54 am |
N/A 2030-04-22 |
RECURSION PHARMACEUTICALS INC. | RXRX | CHAVEZ R. MARTIN Director |
0 | $0 | 525,000 (Direct) |
View |
Ownership |
2021-04-15 08:53 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Burrell Terry-Ann Director |
0 | $0 | 524,999 (Direct) |
View |
Ownership |
2021-04-15 08:53 am |
N/A N/A |
RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director |
0 | $0 | 7,682,106 (Direct) |
View |